Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0046 | ||||
| Gene Name | ABCA8 | ||||
| Protein Name | ATP-binding cassette sub-family A member 8 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | ABCA8; KIAA0822; ATP-binding cassette A member 8 | ||||
| DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
| Cholesterol/Phospholipid/Retinal (CPR) Flippase Family (ABCA) | |||||
| Tissue Specificity | Widely expressed with higher expression inheart, skeletal muscle and liver. | ||||
| Function | This lipophilic drug transporter is ATP-dependent. | ||||
| Endogenous Substrate(s) | Estradiol-beta-glucuronide; Leukotriene C4 | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Estrone sulfate
|
Approved | Drug Info | Menopausal symptoms | MF32 | [1] |
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Aminohippuric acid
|
Withdrawn | Drug Info | Renal function tests | MG02 | [1] |
|
Sodium taurocholate
|
Preclinical | Drug Info | Type 2 diabetes | 5A11 | [1] |
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Estrone sulfate | Approved | Drug Info | Xenopus laevis oocytes-ABCA8 | Km = 0.5 microM | [1] |
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 3 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Aminohippuric acid | Withdrawn | Drug Info | Xenopus laevis oocytes-ABCA8 | Km = 5 microM | [1] |
| Sodium taurocholate | Preclinical | Drug Info | Xenopus laevis oocytes-ABCA8 | Km = 10.3 microM | [1] |
| Ochratoxin A | Investigative | Drug Info | Xenopus laevis oocytes-ABCA8 | Km = 0.4 microM | [1] |
| References | |||||
| 1 | Functional analysis of ABCA8, a new drug transporter. Biochem Biophys Res Commun. 2002 Oct 18;298(1):41-5. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.